These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22069005)

  • 1. [Evaluation of the Brazilian surveillance system for adverse events following vaccination].
    Monteiro SA; Takano OA; Waldman EA
    Rev Bras Epidemiol; 2011 Sep; 14(3):361-71. PubMed ID: 22069005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for adverse events after DTwP/Hib vaccination in Brazil: sensitivity and factors associated with reporting.
    Monteiro SA; Takano OA; Waldman EA
    Vaccine; 2010 Apr; 28(18):3127-33. PubMed ID: 20197140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of electronic immunization registry in the surveillance of adverse events following immunization.
    Sato APS; Ferreira VLR; Tauil MC; Rodrigues LC; Barros MB; Martineli E; Costa ÂA; Inenami M; Waldman EA
    Rev Saude Publica; 2018 Feb; 52():4. PubMed ID: 29412373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system.
    Pan X; Lv H; Chen F; Wang Y; Liang H; Shen L; Chen Y; Hu Y
    Hum Vaccin Immunother; 2021 Oct; 17(10):3823-3830. PubMed ID: 34170800
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China.
    Hu Y; Pan X; Chen F; Wang Y; Liang H; Shen L; Chen Y; Lv H
    Hum Vaccin Immunother; 2022 Dec; 18(1):2035141. PubMed ID: 35240930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015-2018.
    Hu R; Peng S; Liu Y; Tang F; Wang Z; Zhang L; Gao J; Guo H
    BMC Public Health; 2021 Jul; 21(1):1338. PubMed ID: 34229643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the contextual nature of vaccine safety monitoring: Adverse events reporting after HPV-vaccination in Denmark, 2015.
    Schartau S; Heering Holt D; Lützen T; Rytter D; Mølbak K
    Vaccine; 2019 May; 37(19):2580-2585. PubMed ID: 30967312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015.
    Lei J; Balakrishnan MR; Gidudu JF; Zuber PLF
    Vaccine; 2018 Mar; 36(12):1577-1582. PubMed ID: 29454518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccine safety: description of the adverse events reported to the surveillance system in Chile, 2014 to 2016].
    Thomsen P O; Saldaña V A; Cerda L J; Abarca V K
    Rev Chilena Infectol; 2019 Aug; 36(4):461-468. PubMed ID: 31859770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine safety surveillance informs public health policy beyond immunization: A case-series on bleeding following vaccination, Nepal, 2016-2018.
    Pradhan R; Sharma Gautam J; Tinkari BS; Adhikari N; Bose AS
    Vaccine; 2020 Sep; 38(40):6320-6326. PubMed ID: 32788134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.
    Ouandaogo CR; Yaméogo TM; Diomandé FV; Sawadogo C; Ouédraogo B; Ouédraogo-Traoré R; Pezzoli L; Djingarey MH; Mbakuliyemo N; Zuber PL
    Vaccine; 2012 May; 30 Suppl 2():B46-51. PubMed ID: 22230584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka.
    De Alwis KN; Abeysinghe MR; Wickramesinghe AR; Wijesinghe PR
    Vaccine; 2014 Feb; 32(8):924-30. PubMed ID: 24406391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events following HPV vaccination, Alberta 2006-2014.
    Liu XC; Bell CA; Simmonds KA; Svenson LW; Russell ML
    Vaccine; 2016 Apr; 34(15):1800-5. PubMed ID: 26921782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination system.
    Alguacil-Ramos AM; Muelas-Tirado J; Garrigues-Pelufo TM; Portero-Alonso A; Diez-Domingo J; Pastor-Villalba E; Lluch-Rodrigo JA
    Public Health; 2016 Jun; 135():66-74. PubMed ID: 26976484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events following Quadrivalent HPV vaccination reported in Sao Paulo State, Brazil, in the first three years after introducing the vaccine for routine immunization (March 2014 to December 2016).
    Mauro AB; Fernandes EG; Miyaji KT; Arantes BA; Valente MG; Sato HK; Sartori AMC
    Rev Inst Med Trop Sao Paulo; 2019 Sep; 61():e43. PubMed ID: 31531621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active surveillance study of adverse events following immunisation of children in the Czech Republic.
    Danova J; Kocourkova A; Celko AM
    BMC Public Health; 2017 Feb; 17(1):167. PubMed ID: 28166783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active surveillance of adverse events following childhood immunization in Singapore.
    Thoon KC; Soh SB; Liew WK; Gunachandran A; Tan NW; Chong CY; Yung CF
    Vaccine; 2014 Sep; 32(39):5000-5. PubMed ID: 25045811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study.
    Psihogios A; Brianne Bota A; Mithani SS; Greyson D; Zhu DT; Fung SG; Wilson SE; Fell DB; Top KA; Bettinger JA; Wilson K
    Vaccine; 2022 Jul; 40(31):4065-4080. PubMed ID: 35680501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.